Sunday, May 29, 2016 Current Time: 9:53:41 AM (BST) Market Status: Closed

Increase the speed of the ticker
Set the ticker's scrolling direction to right
 
Market Highlights
Market Price
Top 20 Shares
DSEX  
DS30
News
Latest Share Price
By Trade Code
By % Change
By Value
By Volume
By Last Trade Price
By Group
By Alphabetic Order
In Text Mode
DEBT Board
Search Company
 
Enter Company's Trading code

Company Name: Ambee Pharma
Company Information
Untitled Document
Trading Code: AMBEEPHA Scrip Code: 18451
Untitled Document


Figure in BDT    
Market Information: May 29, 2016

Last Trading Price -
Last Update 9:34 AM
Change*
-
-
Opening Price -
Adjusted Opening Price 303.20
Yesterday's Closing Price 303.20
Closing Price -
Day's Range -
Day's Value (mn) -
52 Weeks' Moving Range 243.10 - 363.00
Day's Volume (Nos.) 0
Day's Trade (Nos.) 0
Market Capitalization (mn) 727.680

*Based on Yesterday's Closing Price and Last Trading Price.

 

Basic Information

Authorized Capital (mn) 25.00
Paid-up Capital (mn) 24.00
Face/par Value 10.0
Total No. of Outstanding Securities 2,400,000
Debut Trading Date
Type of Instrument Equity
Market Lot 1
Sector Pharmaceuticals & Chemicals

 

Closing Price Graph:     Total Trade Graph:     Total Volume Graph:    

 

Last AGM held on: 14/06/2015
For the year ended: Dec 31, 2014

Cash Dividend -
Bonus Issue (Stock Dividend) 20% 2013
Right Issue n/a
Year End 31-Dec
Reserve & Surplus without OCI (mn) 34.1
Other Comprehensive Income (OCI) (mn) 0.0

 

Interim Financial Performance: 2015

Particulars Unaudited / Audited
Q1 Q2 Half Yearly Q3 9 Months
201509
Annual
Ending on Ending on 6 Months
201506
Ending on Ending on
201503 201506 201509
Turnover/Revenue (mn) 83.97 108.38 192.35 86.57 278.92 -
Profit from continuing operations (mn) 1.85 2.28 4.13 3.31 7.43 -
Profit for the period (mn) 1.85 2.28 4.13 3.31 7.43 -
Total Comprehensive Income for the period (mn) 1.85 2.28 4.13 3.31 7.43 -
Earnings Per Share (EPS)
Basic 0.770 0.950 1.720 1.380 3.100 -
Diluted* - - - - - -
Earnings Per Share (EPS) - continuing operations
Basic 0.770 0.950 1.720 1.380 3.100 -
Diluted* - - - - - -
Market price per share at period end 325.7 249.6 249.6 271.5 271.5 -

*As per BSEC Directive No. SEC/CMRRCD/2009-193/64, dated September 21, 2010.
Untitled Document

 

Price Earnings (P/E) Ratio based on latest Un-audited Financial Statements

Particulars May 18, 2016May 19, 2016May 22, 2016May 24, 2016May 25, 2016May 26, 2016
Current P/E Ratio using Basic EPS
(Continuing core operations)**
70.571.4770.6570.2171.1873.35
Current P/E ratio using Diluted EPS***
(Continuing core operation)
------

 

Price Earnings (P/E) Ratio Based on latest Audited Financial Statements

Particulars May 18, 2016May 19, 2016May 22, 2016May 24, 2016May 25, 2016May 26, 2016
Current P/E Ratio using Basic EPS
(Continuing core operations)**
93.194.3893.2992.7293.9996.87
Current P/E ratio using Diluted EPS***
(Continuing core operation)
------

** Usually refers to "Continuing operations".
*** Calculated using bonus-adjusted number of shares as per BSEC Directive (not as per IAS 33 or BAS 33).

 

Financial Performance as per Audited Financial Statements as per IFRS/IAS or BFRS/BAS

Year Earnings per share(EPS) EPS - Continuing Operations NAV Per Share Profit/(Loss) and OCI
Basic Diluted
Basic Diluted
Profit from Continuing Operations (mn) Profit for the year (mn) Total Comprehensive Income for the year (mn)
Original Restated Original Restated Original Restated Diluted
2010 - - - 3.68 - - 24.40 - - 7.37 - -
2011 - - - 3.81 - - 25.20 - - 7.62 - -
2012 - - - 3.94 - - 26.14 - - 7.87 - -
2013 - - - 3.95 3.29 - 26.79 22.32 - 7.90 - -
2014 - - - 3.13 - - 24.21 - - 7.52 - -

 

Financial Performance... (Continued)

Year Year end Price Earnings (P/E) ratio Dividend in %* Dividend Yield in %
Earnings per share(EPS) EPS - Continuing Operations
Using Basic EPS Using
Diluted EPS
Using Basic EPS Using
Diluted EPS
Original Restated
Original Restated
2010 - - - 135.11 135.11 - 30.00 0.60
2011 - - - 110.47 110.47 - 30.00 0.71
2012 - - - 57.54 57.54 - 33.00 1.46
2013 - - - 78.88 78.88 - 15.00, 20%B 0.58
2014 - - - 82.01 - - 28.00 1.09

*B for bonus or stock dividend, otherwise cash.

 

Details of Financial Statement
Price Sensitive Information

 

Other Information of the Company

Listing Year 1986
Market Category A
Electronic Share Y
Share Holding Percentage [as on Dec 31, 2014 (year ended)]
Sponsor/Director:
66.31
Govt:
0.00
Institute:
3.25
Foreign:
8.95
Public:
21.49
Remark

 

Corporate Performance at a glance

Present Operational Status
Present Loan Status as on December 31, 2014
  Short-term loan (mn) 0
Long-term loan (mn) 0
Latest Dividend Status (%) 28.00 for 2014
Latest Credit Rating Status
  Short-term
Long-term
OTC/Delisting/Relisting

 

Address of the Company

Address 184/1, Tejgaon Industrial Area
Dhaka-1208
Contact Phone (880-2) 8870897, 8870599
Fax (880-2) 8870799
E-mail info@ambeepharma.com
Web Address http://www.ambeepharma.com

 

Disclaimer: This page is now under updating process. If any anomalies are found , please inform us (phone: 88-02-9564601, 7175703-11, Ext- 290).

 




STOCK EXCHANGE BUILDING, 9/F MOTIJHEEL C/A, DHAKA BANGLADESH
Phone: 88-02-9564601, 7175703-11, FAX: +88-02-9564727
Email: dse@bol-online.com, Web: http://www.dsebd.org/
 

Home | Download | Data Archives | Career at DSE | FAQ | Sitemap | Links
Disclaimer Copyright Dhaka Stock Exchange 2011 Terms & Conditions
 

Powered By Bangladesh Online a division of Bangladesh Export Import Company Ltd.